Patent details
EP3270966 Title: COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT OF CANCER WHEREIN THE COMBINATION DOES NOT COMPRISE 5-AZACYTIDINE.
Basic Information
- Publication number:
- EP3270966
- PCT Application Number:
- US2016023298
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP167694603
- PCT Publication Number:
- WO2016154068
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION OF HDAC INHIBITOR AND ANTI-PD-1 ANTIBODY FOR TREATMENT OF CANCER WHEREIN THE COMBINATION DOES NOT COMPRISE 5-AZACYTIDINE.
- French Title of Invention:
- ASSOCIATION D'UN INHIBITEUR DE L'HISTONE DÉSACÉTYLASE (HDAC) AVEC UN ANTICORPS ANTI-PD-1 POUR LE TRAITEMENT DU CANCER, LA COMBINAISON NE COMPRENANT PAS DE 5-AZACYTIDINE.
- German Title of Invention:
- KOMBINATION AUS EINEM HDAC-HEMMER UND EINEM ANTI-PD-1-ANTIKÖRPER, WOBEI DIE KOMBINATION KEIN 5-AZACYTIDIN ENTHÄLT, ZUR BEHANDLUNG VON KREBS.
- SPC Number:
Dates
- Filing date:
- 18/03/2016
- Grant date:
- 01/05/2024
- EP Publication Date:
- 24/01/2018
- PCT Publication Date:
- 29/09/2016
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/05/2024
- EP B1 Publication Date:
- 01/05/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 18/03/2025
- Expiration date:
- 18/03/2036
- Renunciation date:
- Revocation date:
- 24/09/2025
- Annulment date:
Owner
- From:
- 13/06/2024
- Name:
- Syndax Pharmaceuticals, Inc.
- Address:
- 35 Gatehouse Drive Building D, Floor 3, Waltham, Massachusetts 02451, United States (US)
History of Owners
- From:
- 13/06/2024
- To:
- 13/06/2024
- Name:
- Syndax Pharmaceuticals, Inc.
- Address:
- 35 Gatehouse Drive Building D, Floor 3, Waltham, Massachusetts 02451, United States (US)
- From:
- 24/04/2024
- To:
- 13/06/2024
- Name:
- Syndax Pharmaceuticals Inc.
- Address:
- 400 Totten Pond Road Suite 110, Waltham, MA 02451, United States (US)
Inventor
1
- Name:
- GOODENOW, Robert
- Address:
- United States (US)
2
- Name:
- ORDENTLICH, Peter
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201562136303 P
- Priority Date:
- 20/03/2015
- Priority Country:
- United States (US)
2
- Priority Number:
- 201562137601 P
- Priority Date:
- 24/03/2015
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07K 16/28; A61K 39/395; A61P 35/00; A61K 31/4406;
Publication
European Patent Bulletin
1
- Issue number:
- 202418
- Publication date:
- 01/05/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202607
- Publication date:
- 11/02/2026
- Description:
- Revocation of the European patent
3
- Issue number:
- 202429
- Publication date:
- 17/07/2024
- Description:
- Change of owner's name or address
4
- Issue number:
- 202429
- Publication date:
- 17/07/2024
- Description:
- Change of owner's name or address
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|